Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.525 USD | +2.01% | -2.58% | -17.93% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.93% | 170M | |
-16.80% | 8.79B | |
+65.89% | 4.19B | |
-4.03% | 2.48B | |
-42.54% | 2.29B | |
-6.30% | 1.97B | |
-19.90% | 1.56B | |
-41.24% | 1.22B | |
+10.26% | 1.13B | |
+18.74% | 933M |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix Strikes New Research Deal With Memorial Sloan Kettering Cancer Center